Clinical Trial: Prospective observation of FABP4 and its related signaling axis expression in the placental immune microenvironment of patients with gestational diabetes and its impact on macrophage polarization (China)

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective observation of FABP4 and its related signaling axis expression in the placental immune microenvironment of patients with gestational diabetes and its impact on macrophage polarization'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132461

Registration Time: 2026/09/14

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of fujian medical university

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=320882

Published by HT Digital Content Services with permission from Health Daily Digest....